From Wikipedia, the free encyclopedia
Chemical compound
Esreboxetine (developmental code names AXS-14, PNU-165442G ) is a
selective
norepinephrine reuptake inhibitor which was under development by
Pfizer for the treatment of
neuropathic pain and
fibromyalgia but failed to show significant benefit over currently available medications and was discontinued.
[1]
[2]
[3]
[4] It is the (S ,S )-(+)-
enantiomer of
reboxetine and is even more selective as a norepinephrine reuptake inhibitor in comparison.
[1]
[5]
However, recently it has been found that esreboxetine could be effective in fibromyalgia patients.
[6]
References
^
a
b Bingham M, Napier SJ (2009).
Transporters as Targets for Drugs (Topics in Medicinal Chemistry) . Berlin: Springer.
ISBN
978-3-540-87911-4 .
^ Rao SG (October 2009). "Current progress in the pharmacological therapy of fibromyalgia". Expert Opinion on Investigational Drugs . 18 (10): 1479–1493.
doi :
10.1517/13543780903203771 .
PMID
19732029 .
S2CID
12726987 .
^
"Search of esreboxetine" . ClinicalTrials.gov .
^ Kelly J (26 February 2009).
"Pfizer Stops Work on Esreboxetine for FM" . Musculoskeletal Report . New York, NY. Archived from
the original on 29 February 2012.
^ Fish PV, Mackenny M, Bish G, Buxton T, Cave R, Drouard D, et al. (2009). "Enantioselective synthesis of (R)- and (S)-N-Boc-morpholine-2-carboxylic acids by enzyme-catalyzed kinetic resolution: application to the synthesis of reboxetine analogs". Tetrahedron Letters . 50 (4): 389–391.
doi :
10.1016/j.tetlet.2008.11.025 .
^ Arnold LM, Hirsch I, Sanders P, Ellis A, Hughes B (July 2012). "Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial". Arthritis and Rheumatism . 64 (7): 2387–2397.
doi :
10.1002/art.34390 .
PMID
22275142 .
DAT Tooltip Dopamine transporter (
DRIs Tooltip Dopamine reuptake inhibitors )
NET Tooltip Norepinephrine transporter (
NRIs Tooltip Norepinephrine reuptake inhibitors )
Others:
Antihistamines (e.g.,
brompheniramine ,
chlorphenamine ,
pheniramine ,
tripelennamine )
Antipsychotics (e.g.,
loxapine ,
ziprasidone )
Arylcyclohexylamines (e.g.,
ketamine ,
phencyclidine )
Dopexamine
Ephenidine
Ginkgo biloba
Indeloxazine
Nefazodone
Opioids (e.g.,
desmetramadol ,
methadone ,
pethidine (meperidine) ,
tapentadol ,
tramadol ,
levorphanol )
SERT Tooltip Serotonin transporter (
SRIs Tooltip Serotonin reuptake inhibitors )
Others:
A-80426
Amoxapine
Antihistamines (e.g.,
brompheniramine ,
chlorphenamine ,
dimenhydrinate ,
diphenhydramine ,
mepyramine (pyrilamine) ,
pheniramine ,
tripelennamine )
Antipsychotics (e.g.,
loxapine ,
ziprasidone )
Arylcyclohexylamines (e.g.,
3-MeO-PCP ,
esketamine ,
ketamine ,
methoxetamine ,
phencyclidine )
Cyclobenzaprine
Delucemine
Dextromethorphan
Dextrorphan
Efavirenz
Hypidone
Medifoxamine
Mesembrine
Mifepristone
MIN-117 (WF-516)
N-Me-5-HT
Opioids (e.g.,
dextropropoxyphene ,
methadone ,
pethidine (meperidine) ,
levorphanol ,
tapentadol ,
tramadol )
Roxindole
VMATs Tooltip Vesicular monoamine transporters Others